Sintim, Herman O
- Indiana University Indianapolis · Microbiology & Immunology (NIH department code)
- Purdue University · Pharmacology (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #11,018
- Rising Star
- R01 Holder
- Translational
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Microbiology & Immunology
- Pharmacology
NIH Funding · FY2023
Linked Award Amount
$941.6K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#11,018
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Sintim, Herman O as a PI. Multi-PI records show the full award amount for context.
- 5R01AI152235-04R01Contact PITargeting Cyclic Dinucleotide Signaling Pathways to Interrupt the Nature Cycle of Borrelia burgdorferiIndiana University Indianapolis · Microbiology & Immunology (NIH department code)$560.2Kaward amount
- 5R01CA177585-08R01Contact PITargeting MYC promoter G-quadruplex for MYC inhibition by IndenoisoquinolinesPurdue University · Pharmacology (NIH department code)$381.4Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Sintim, Herman O as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardIndiana University Indianapolis
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #8988
- 2021Multi-Institutional ResearchAwards at 2 institutions
- 2021R01 Grant Holder
- 2022$2M Cumulative Funding
- 2022Entered Top 25% NationallyRanked #3675